Back

Combinations of antithrombotic therapies prescribed after percutaneous coronary intervention in patients with acute coronary syndromes and atrial fibrillation: data from the nationwide MATADOR-PCI registry

European Heart Journal - Cardiovascular Pharmacotherapy

11 July 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Leonardo De Luca
Leonardo De Luca

Author

Foundation IRCCS Policlinic San Matteo - University of Pavia Pavia , Italy

Leonardo Bolognese
Leonardo Bolognese

Author

Andrea Rubboli
Andrea Rubboli

Author

Alfredo Vetrano
Alfredo Vetrano

Author

Mariella Callerame
Mariella Callerame

Author

Luigi Rivetti
Luigi Rivetti

Author

Lucio Gonzini
Lucio Gonzini

Author

Domenico Gabrielli
Domenico Gabrielli

Author

Andrea Di Lenarda
Andrea Di Lenarda

Author

Michele Massimo Gulizia
Michele Massimo Gulizia

Author

You may be interested in
thumbnail
Congress Presentation
Expert discussion: how to balance antithrombotic benefit and risk in atrial fibrillation patients with acute coronary syndrome undergoing percutaneous coronary intervention?
4 April 2022
thumbnail
Congress Presentation
Antiplatelet therapy prescription patterns for acute coronary syndrome: a decade analysed
28 August 2020
thumbnail
Congress Presentation
Impact of clopidogrel metabolizer status on platelet aggregation and association with outcomes in AF patients undergoing PCI
30 August 2025
thumbnail
Congress Presentation
The effect of concomitant AF on in-hospital clinical outcomes of NSTE-ACS related hospitalizations in the United States: an analysis of rates, trends and predictors from 2004 to 2014.
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources